Butterfly Network is exploding higher today, driven primarily by positive analyst sentiment following an initiation of coverage by Needham. On September 22, 2026, analyst David Saxon issued a Buy rating on the stock with a price target of $10.00, citing the company's potential in the medical device space. This bullish outlook has provided significant momentum, pushing the stock toward its 52-week high of $10.05 and keeping it well above its 50-day moving average.